Literature DB >> 17457229

Multimodality treatment of stage IIIA and IIIB non-small cell lung cancer.

Wilfried Eberhardt1, Thomas Gauler, Christoph Pöttgen, Thomas Krbek, Sönke Korfee, Georgios Stamatis, Martin Stuschke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17457229     DOI： 10.1097/01.JTO.0000268640.56073.d1

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer.

Authors:  Ferdinando Riccardi; Giuseppe Di Lorenzo; Carlo Buonerba; Guglielmo Monaco; Roberto Monaco; Mimma Rizzo; Sarah Scagliarini; Florinda Scognamiglio; Marilena Di Napoli; Giacomo Carteni'
Journal:  World J Surg Oncol       Date:  2010-02-05       Impact factor: 2.754

2.  Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment.

Authors:  Alessandro Marra; Gunther Richardsen; Wolfgang Wagner; Carsten Müller-Tidow; Olaf M Koch; Ludger Hillejan
Journal:  Thorac Surg Sci       Date:  2011-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.